tiprankstipranks
Trending News
More News >
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
Germany Market
Advertisement

Fresenius Medical Care AG & Co. KGaA (FME) Ratios

Compare
11 Followers

Fresenius Medical Care AG & Co. KGaA Ratios

DE:FME's free cash flow for Q1 2025 was €0.24. For the 2025 fiscal year, DE:FME's free cash flow was decreased by € and operating cash flow was €0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.46 1.42 1.27 1.10 1.18
Quick Ratio
1.08 1.07 0.91 0.82 0.87
Cash Ratio
0.20 0.23 0.20 0.20 0.18
Solvency Ratio
0.13 0.11 0.12 0.13 0.14
Operating Cash Flow Ratio
0.44 0.43 0.34 0.34 0.69
Short-Term Operating Cash Flow Coverage
3.53 2.78 1.59 1.29 3.89
Net Current Asset Value
€ -9.27B€ -10.40B€ -12.10B€ -12.42B€ -12.08B
Leverage Ratios
Debt-to-Assets Ratio
0.33 0.36 0.37 0.39 0.39
Debt-to-Equity Ratio
0.75 0.88 0.86 0.95 1.00
Debt-to-Capital Ratio
0.43 0.47 0.46 0.49 0.50
Long-Term Debt-to-Capital Ratio
0.30 0.34 0.32 0.32 0.36
Financial Leverage Ratio
2.28 2.49 2.31 2.46 2.57
Debt Service Coverage Ratio
2.51 1.92 1.68 1.35 2.23
Interest Coverage Ratio
3.52 3.22 -0.72 0.85 1.29
Debt to Market Cap
0.50 0.71 0.95 0.51 0.39
Interest Debt Per Share
38.24 42.52 46.28 46.67 43.50
Net Debt to EBITDA
3.18 3.63 3.71 3.46 2.95
Profitability Margins
Gross Profit Margin
24.46%25.32%27.37%28.82%31.00%
EBIT Margin
7.57%6.79%7.73%10.40%12.59%
EBITDA Margin
15.72%15.08%16.60%19.39%21.47%
Operating Profit Margin
7.21%7.04%-1.33%1.71%2.96%
Pretax Profit Margin
5.53%5.31%6.29%8.92%10.84%
Net Profit Margin
3.17%2.57%3.47%5.50%6.52%
Continuous Operations Profit Margin
3.62%3.14%4.61%6.92%8.04%
Net Income Per EBT
57.38%48.30%55.20%61.66%60.14%
EBT Per EBIT
76.66%75.43%-472.20%521.70%365.97%
Return on Assets (ROA)
1.89%1.47%1.88%2.82%3.67%
Return on Equity (ROE)
4.38%3.66%4.36%6.93%9.44%
Return on Capital Employed (ROCE)
5.15%4.92%-0.88%1.11%2.07%
Return on Invested Capital (ROIC)
3.38%3.30%-0.61%0.79%1.44%
Return on Tangible Assets
3.69%2.78%3.65%5.23%6.71%
Earnings Yield
4.55%4.48%7.51%5.79%5.81%
Efficiency Ratios
Receivables Turnover
5.43 4.79 5.21 4.92 5.47
Payables Turnover
16.44 19.06 14.80 14.63 14.89
Inventory Turnover
7.08 6.67 6.14 6.15 6.50
Fixed Asset Turnover
2.79 2.61 4.63 4.08 4.32
Asset Turnover
0.60 0.57 0.54 0.51 0.56
Working Capital Turnover Ratio
8.17 8.99 15.87 19.32 28.06
Cash Conversion Cycle
96.58 111.79 104.83 108.53 98.34
Days of Sales Outstanding
67.26 76.19 69.99 74.17 66.70
Days of Inventory Outstanding
51.52 54.75 59.49 59.31 56.14
Days of Payables Outstanding
22.21 19.15 24.65 24.96 24.51
Operating Cycle
118.78 130.94 129.49 133.48 122.84
Cash Flow Ratios
Operating Cash Flow Per Share
8.25 8.96 7.39 8.50 14.40
Free Cash Flow Per Share
6.76 6.63 2.58 2.75 7.29
CapEx Per Share
2.42 2.33 4.81 5.75 7.10
Free Cash Flow to Operating Cash Flow
0.82 0.74 0.35 0.32 0.51
Dividend Paid and CapEx Coverage Ratio
2.28 2.59 1.20 1.20 1.74
Capital Expenditure Coverage Ratio
3.40 3.84 1.54 1.48 2.03
Operating Cash Flow Coverage Ratio
0.22 0.22 0.16 0.19 0.34
Operating Cash Flow to Sales Ratio
0.12 0.14 0.11 0.14 0.24
Free Cash Flow Yield
14.59%17.46%8.43%4.82%10.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.99 22.32 13.31 17.27 17.22
Price-to-Sales (P/S) Ratio
0.70 0.57 0.46 0.95 1.12
Price-to-Book (P/B) Ratio
0.95 0.82 0.58 1.20 1.63
Price-to-Free Cash Flow (P/FCF) Ratio
6.85 5.73 11.86 20.77 9.35
Price-to-Operating Cash Flow Ratio
5.61 4.24 4.14 6.73 4.74
Price-to-Earnings Growth (PEG) Ratio
1.44 -0.86 -0.44 -1.05 0.00
Price-to-Fair Value
0.95 0.82 0.58 1.20 1.63
Enterprise Value Multiple
7.62 7.43 6.49 8.36 8.18
Enterprise Value
23.34B 21.78B 20.90B 28.58B 31.35B
EV to EBITDA
7.62 7.43 6.49 8.36 8.18
EV to Sales
1.20 1.12 1.08 1.62 1.76
EV to Free Cash Flow
11.77 11.21 27.65 35.46 14.62
EV to Operating Cash Flow
9.64 8.29 9.65 11.48 7.41
Tangible Book Value Per Share
-1.59 -4.04 -6.35 -6.29 -6.83
Shareholders’ Equity Per Share
48.98 46.42 52.68 47.72 41.93
Tax and Other Ratios
Effective Tax Rate
0.31 0.29 0.27 0.22 0.26
Revenue Per Share
66.43 66.30 66.15 60.14 60.73
Net Income Per Share
2.11 1.70 2.30 3.31 3.96
Tax Burden
0.57 0.48 0.55 0.62 0.60
Interest Burden
0.73 0.78 0.81 0.86 0.86
Research & Development to Revenue
<0.01 0.01 0.01 0.01 0.01
SG&A to Revenue
0.06 0.12 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 <0.01 >-0.01 <0.01 <0.01
Income Quality
3.42 3.59 2.42 2.04 2.95
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis